We are live on ! Find out more
IGMS

IGM Biosciences

Delisted

IGMS was delisted on the 13th of August, 2025.

1 hedge funds and large institutions have $508 invested in IGM Biosciences in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

45.9% less ownership

Funds ownership: 45.9%0% (-46%)

98% less funds holding

Funds holding: 661 (-65)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less capital invested

Capital invested by funds: $17.9M → $508 (-$17.9M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 65

Holders
1
Holders Change
-65
Holders Change %
-98.48%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
65
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

IGMS Hedge Fund Activity: Q3 2025 in Review

1 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in IGM Biosciences (IGMS) for Q3 2025, worth a combined $508 — down 100% from $17.9M a quarter earlier.

Sellers outnumbered buyers: 65 funds closed out of IGMS and 0 opened new positions — a net loss of 65 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $4.59M sold.

  • 1 institutional investor held IGM Biosciences (IGMS) as of Q3 2025, down from 66 in Q2 2025.
  • Funds reported $508 of IGM Biosciences stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new IGM Biosciences positions in Q3 2025 and 65 closed out, a net change of -65 holders.
  • The largest IGM Biosciences seller in Q3 2025 was Baker Bros. Advisors, an estimated $4.59M sold.

Based on aggregated 13F filings for Q3 2025.